Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tullis-Dickerson is a healthcare-focused venture capital firm that provides equity capital to small and medium-sized companies in the life sciences and healthcare services sectors. Founded in 1986, the firm has historically invested across various sub-sectors, including biotechnology, medical devices, and healthcare information technology. The firm's investment strategy typically focuses on companies with proven technologies or business models that are entering a growth phase. Over its history, Tullis-Dickerson has managed multiple funds and supported numerous portfolio companies through to successful exits via IPOs or acquisitions. The firm has since evolved into Tullis Health Investors, continuing its legacy of specialized healthcare investment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Tullis-Dickerson.